1. |
Cribier A. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
|
2. |
Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. The Lancet, 2015, 385(9986): 2485-2491.
|
3. |
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg, 2014, 148(1): e1-e132.
|
4. |
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
|
5. |
Yousef A, MacDonald Z, Simard T, et al. Transcatheter aortic valve implantation (tavi) for native aortic valve regurgitation- a systematic review. Circ J, 2018, 82(3): 895-902.
|
6. |
Bleiziffer S, Mazzitelli D, Nobauer C, et al. Successful treatment of pure aortic insufficiency with transapical implantation of the JenaValve. Thorac Cardiovasc Surg, 2013, 61(5): 428-430.
|
7. |
Franzone A, Piccolo R, Siontis GC, et al. Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review. JACC Cardiovasc Interv, 2016, 9(22): 2308-2317.
|
8. |
Seiffert M, Bader R, Kappert U, et al. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation. JACC Cardiovasc Interv, 2014, 7(10): 1168-1174.
|
9. |
Zhu D, Hu J, Meng W, et al. Successful transcatheter aortic valve implantation for pure aortic regurgitation using a new second generation self-expanding J-Valve(TM) system - the first in-man implantation. Heart Lung Circ, 2015, 24(4): 411-414.
|
10. |
Yan J, Duan J, Wu X, et al. Total saponins from Aralia taibaiensis protect against myocardial ischemia/reperfusion injury through AMPK pathway. Int J Mol Med, 2015, 36(6): 1538-1546.
|
11. |
Zhu D, Chen Y, Zhang J, et al. Transapical implantation of a new second-generation transcatheter heart valve in patients with pure aortic regurgitation: a preliminary report. Interact Cardiovasc Thorac Surg, 2015, 20(6): 860-862.
|
12. |
Zhu D, Wei L, Cheung A, et al. Treatment of pure aortic regurgitation using a second-generation transcatheter aortic valve implantation system. J Am Coll Cardiol, 2016, 67(23): 2803-2805.
|
13. |
Head SJ, Bogers AJJC, Serruys PW, et al. A crucial factor in shared decision making: the team approach. The Lancet, 2011, 377(9780): 1836.
|
14. |
Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg, 2013, 145(1): 6-23.
|
15. |
Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J, 2008, 29(11): 1463-1470.
|
16. |
Schaefer BM, Lewin MB, Stout KK, et al. The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape. Heart, 2008, 94(12): 1634-1638.
|
17. |
Reardon MJ, Adams DH, Kleiman NS, et al. 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol, 2015, 66(2): 113-121.
|
18. |
Holmes DR, Jr., Mack MJ, Kaul S, et al ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol, 2012, 59(13): 1200-1254.
|
19. |
Kiefer P, Seeburger J, Mohr FW, et al. Transcatheter aortic valve replacement for isolated aortic valve insufficiency: experience with the Engager valve. J Thorac Cardiovasc Surg, 2014, 147(4): e37-38.
|
20. |
Fei X, Elhmidi Y, Zhang B, et al. Transapical transcatheter aortic valve implantation using a new tavi system for high-risk patients with severe aortic stenosis. Heart Lung Circ, Heart Lung Circ, 2018, 27(6): e67-e69.
|
21. |
Buellesfeld L, Gerckens U, Schuler G, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol, 2011, 57(16): 1650-1657.
|
22. |
Osten MD, Feindel C, Greutmann M, et al. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes. Catheter Cardiovasc Interv, 2010, 75(4): 475-485.
|
23. |
Ruparelia N, Thomas K, Newton JD, et al. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single centre experience. Cardiovasc Revasc Med, 2018, 19(1 Pt B): 78-82.
|
24. |
Krasopoulos G, Falconieri F, Benedetto U, et al. European real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registries. J Cardiothorac Surg, 2016, 11(1): 159.
|
25. |
Sawaya FJ, Deutsch MA, Seiffert M, et al. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study. JACC Cardiovasc Interv, 2017, 10(10): 1048-1056.
|
26. |
Ussia GP, Barbanti M, Petronio AS, et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J, 2012, 33(8): 969-976.
|
27. |
Gurvitch R, Wood DA, Tay EL, et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation, 2010, 122(13): 1319-1327.
|
28. |
Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol, 2013, 61(15): 1577-1584.
|
29. |
Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA, 2014, 311(15): 1503-1514.
|
30. |
Kaya D, Tanriverdi Z, Dursun H, et al. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre. Int J Cardiovasc Imaging, 2016, 32(9): 1371-1378.
|
31. |
Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol, 2013, 61(15): 1585-1595.
|
32. |
Testa L, Latib A, Rossi ML, et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention, 2014, 10(6): 739-745.
|
33. |
Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med, 2014, 370(19): 1790-1798.
|
34. |
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med, 2016, 374(17): 1609-1620.
|
35. |
Schlingloff F, Schafer U, Frerker C, et al. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up. Interact Cardiovasc Thorac Surg, 2014, 19(3): 388-393.
|